We found that API treatment significantly reduced miR-155 gene expression in the tumors from KC-HPC mice compared with vehicle treated KC-HPC mice (Figure 5A), and significantly increased the gene and protein expressions of SHIP-1 (Figure 5B–D). The gene discussed is INPP5D; the disease is keratoconus.